ORIG3N Alternatives & Competitors

12 companies similar to ORIG3N

Dicerna Pharmaceuticals

Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference te...

201-500 Post-IPO Equity $420.45M

Biotechnology Health Care +1

Vigil Neuroscience

Harnessing the power of microglia to transform treatments for neurodegenerative diseases

76 Acquired $650.00M

Watertown, United States

Biotechnology Health Care

Merck & Co., Inc.

Merck develops and produces medicines, vaccines, biologic therapies and animal health prod...

92 IPO $8.36B

Biotechnology Health Care +1

Nobias Therapeutics

Clinical-stage company developing novel small molecule therapeutics for rare diseases

12 Series A $3.75M

Philadelphia, United Stat...

Health Care Health and Wellness

Track all ORIG3N competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

SIWA Therapeutics

9 Venture round $1.63M

Chicago, United States

Biotechnology Health and Wellness

Kate Therapeutics

New Hope for Patients with Muscle and Heart Disease

48 Acquired $1.17B

San Diego, United States

Biotechnology Health Care +1

GeNeuro SA

We focus on Human Endogenous Retroviruses (#HERVs) to fight neurodegeneration in #MS, #ALS...

17 Post-IPO Equity $49.90M

Biotechnology Health Care +1

Inipharm

Inipharm is a biopharmaceutical company focused on discovering and developing therapies fo...

7 Series A $35.00M

Biotechnology Health Care +1

Alector

We are on a mission to make brain disorders history.

141 IPO $495.50M

South San Francisco, Unit...

Biotechnology Health Care +2

ProMIS™ Neurosciences, Inc.

Precision therapeutics for protein misfolding disorders, including Alzheimer's, ALS and Pa...

22 $233.31M

Cambridge, United States

Biotechnology Health Care +1

POXEL

25 Post-IPO Equity $103.50M

Lyon, France

Biotechnology Health Care +1

SpringWorks Therapeutics

372 Post-IPO Equity $1.02B

Stamford, United States

Biopharma Biotechnology +1

Frequently Asked Questions

Companies similar to ORIG3N include Dicerna Pharmaceuticals, Vigil Neuroscience, Merck & Co., Inc., Nobias Therapeutics, SIWA Therapeutics. They work in Biotechnology and Health Care.

Bounce Watch lists 12 companies that share ORIG3N's industries and are closest to it in business tags, services, target customers, business model and size.

ORIG3N is a biotechnology company founded in 2014 and based in Boston, Massachusetts. The company focuses on developing breakthrough treatments for rare genetically inherited diseases, with targets in heart, liver, and neurodegenerative indications. Their latest milestone was a significant $26.17M Venture Round investm...

Don't just read about them. Follow them.

BounceWatch watches ORIG3N and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

ORIG3N Profile Dicerna Pharmaceuticals Alternatives Merck & Co., Inc. Alternatives Nobias Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at ORIG3N on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.